Group One Trading’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Group One Trading’s Portfolio ELOX Stock Details ELOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4	Closed	-$19	–	8512
2023 Q3	$19	Hold	4	–	–	﹤0.01%	7525
2023 Q2	$16	Hold	4	–	–	﹤0.01%	7557
2023 Q1	$10	Hold	4	–	–	﹤0.01%	7091
2022 Q4	$7	Hold	4	–	–	﹤0.01%	7123
2022 Q3	$0	Hold	4	–	–	﹤0.01%	8573
2022 Q2	$0	Sell	4 -1,968	-100%	-$27.2K	﹤0.01%	8837
2022 Q1	$44K	Buy	1,972 +853	+76%	+$16.8K	﹤0.01%	6192
2021 Q4	$31K	Buy	+1,119	New	+$48.8K	﹤0.01%	6716

Other funds holding ELOX

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Group One Trading's ELOX Position: Q4 2023 in Review

Group One Trading sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2023, closing a stake of 4 shares — an estimated $19 sold.

Group One Trading first reported a position in ELOX in Q4 2021 and held it in 8 quarters. The position peaked at $44K in Q1 2022. 4 funds tracked by Wall St. Rank hold ELOX as of Q4 2023.

Group One Trading reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Group One Trading sold 4 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $19.
Group One Trading first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
Group One Trading's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $44K in Q1 2022.
4 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.